Quick Answer
Xenon Pharmaceuticals Inc. reported Total Assets of $633.16 million for fiscal year 2025.
Xenon Pharmaceuticals Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $633.16M | -20.7% |
| 2024 | $798.14M | -17.3% |
| 2023 | $964.80M | +27.9% |
| 2022 | $754.15M | +31.8% |
| 2021 | $572.01M | +202.4% |
| 2020 | $189.19M | +28.1% |
| 2019 | $147.70M | +20.6% |
| 2018 | $122.43M | +165.4% |
| 2017 | $46.12M | -31.7% |
| 2016 | $67.49M | +5.5% |
| 2015 | $63.95M | -26.8% |
| 2014 | $87.42M | +60.4% |
| 2013 | $54.49M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $607.84M | -27.3% | -9.9% |
| June 30, 2025 | $674.28M | -23.7% | -9.3% |
| March 31, 2025 | $743.28M | -19.1% | -6.9% |
| December 31, 2024 | $798.14M | -17.3% | -4.5% |
| September 30, 2024 | $835.90M | +24.6% | -5.4% |
| June 30, 2024 | $884.01M | +29.1% | -3.8% |
| March 31, 2024 | $919.02M | +27.7% | -4.7% |
| December 31, 2023 | $964.80M | +27.9% | +43.8% |
- Xenon Pharmaceuticals Inc. showed a decrease of -20.7% in Total Assets compared to the prior fiscal year.
- Over the 2013–2025 period, Xenon Pharmaceuticals Inc.’s total assets has grown by 1062.0% (from $54.49 million to $633.16 million).
- The most recent figure is from Xenon Pharmaceuticals Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: